BIS (Quality Control) Amendment Order for the Morpholine
CONFORMITY ASSESSMENT & REGULATORY COMPLIANCE
Dear Reader,
Important update regarding Indian Standard applicable to all existing Licence holders/ New applicants/ manufacturers/ importers/ product sellers for the Morpholine Amendment Order (Quality Control), 2020.
BIS (Quality Control) Amendment Order for the Morpholine
OVERVIEW
The Ministry of Chemicals and Fertilizers has introduced the "Morpholine Amendment Order (Quality Control), 2020," scheduled to be effective from 1 August 2024.
This order applies to goods or articles, specifically Morpholine, and extends to those intended for export.
Goods falling under the category of Morpholine must conform to the prescribed Indian Standard IS 12084:2018 and bear the Standard Mark. Manufacturers are required to obtain a license from the Bureau under Scheme-I of Schedule-II of the Bureau of Indian Standards (Conformity Assessment) Regulations, 2018.
The Bureau is designated as both the certifying and enforcing authority for goods or articles falling under the category of Morpholine
Any contravention of the provisions outlined in this order is subject to penalties under the provisions of the relevant Act.
This regulatory measure ensures the quality and conformity of Morpholine in the market, promoting standardized practices and safeguarding consumers and the chemical industry.
Implementation Authority : Bureau of Indian Standards (Govt. of India)
BIS CERTIFICATION FOR MORPHOLINE IS 12084:2018
CONCERNED AUTHORITIES
Bureau of Indian Standards Manak Bhawan 9, B.S. Zafar Marg, New Delhi - 110002
Tel: +91-11-23231903
Email: cmd2@bis.org.in
Implementation Dates: 1 August 2024
For any queries on this update, write us at info@alephindia.in or Call 08048036869
For more details visit: Aleph INDIA
Attachment: Standard Amendment Order issued by Bureau of Indian Standards
Disclaimer: The information provided in this update is intended for informational purposes only. Readers are requested to seek formal legal advice prior to acting upon any of the information provided herein.
© 2022, Aleph INDIA. All Rights Reserved